Reports
Reports
Sale
The global softgel capsules market size was valued at USD 6.1 billion in 2023, driven by the medical advancements to develop easy to swallow capsules that offer enhanced bioavailability across the globe. The market is expected to grow at a CAGR of 7.7% during the forecast period of 2024-2032, with the values likely to rise from USD 6.5 billion in 2024 to USD 11.8 billion by 2032.
A softgel capsule is a capsule shell surrounding a semi-solid or liquid fill, making it suitable for storing oil-based formulations. Softgels contain added ingredients like glycerine to maintain the thick and soft texture. It is highly preferred by the consumers as it is easy to swallow and digest, devoid of any unpleasant taste or smell.
Softgel capsules can be developed in a range of forms, shapes, or sizes, depending on the point of action and material to be filled in. They are the leading formulations for multivitamin capsules and dietary supplements.
When compared to tablets and hard capsules, softgel capsules have gained high popularity in human and animal pharmaceutical applications. This is because they are particularly helpful to formulate low melting point active pharmaceutical ingredients (APIs). They also facilitate better absorption and bioavailability of poorly water-soluble APIs, which can be quite complicated in some tablets.
It is important for a drug to be released at the right time and place for it to work efficiently. With new innovations, softgel capsules are now available with an enteric coating. This coating is applied to the capsule exterior to control the time and place of action. As enteric refers to small intestine, the nutrient is only released when it reaches the small intestine. This coating helps in protecting the compound from stomach and vice-e-versa, preventing a gastric reflux as well. This specificity substantiates the softgel capsule market growth.
The enteric softgel capsules are specially prepared by the addition enteric polymer with the help of inducing cross linked gelatine. It makes the capsule temperature and humidity resistant, helping it maintain the tensile strength along with the smooth and elastic nature. There has been quality development around plant based softgels as well. IFF’s pharma solutions division is ready to launch a pectin-based premix that allows manufacturers to offer carrageenan free products. Such innovations and variations to the existing models indicate that the softgel capsules market demand is destined to rise in the future.
Market Breakup by Type
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by Region
While the softgel capsules market share has been majorly dominated by the North American region, Asian countries are set to experience significant growth during the forecast period. This is because of rising investments to develop a quality infrastructure that supports high end research. This has been successful as well. For instance, earlier this year, Lotus Pharmaceutical launched Vinorelbine softgel capsules (an alkaloid indicated to treat locally advanced or metastatic non-small cell lung cancer) in Vietnam. It is the first and the only Drug Authority of Vietnam (DAV) approved softgel in the Vietnam softgel capsules market.
The emphasis on supplementation has grown post COVID-19, as masses are driven towards natural and immunity boosting products. Since softgel capsules are easy to consume and do not possess any bad taste or smell, they are a preferred alternative to feed supplements to children. Since they also accommodate a wide range of compounds like liquids, semi-solids, emulsions, or suspensions, the softgel capsule market value has seen a significant rise during the historical period.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Softgel Capsules Market Overview
3.1 Global Softgel Capsules Market Historical Value (2017-2023)
3.2 Global Softgel Capsules Market Forecast Value (2024-2032)
4 Global Softgel Capsules Market Landscape
4.1 Global Softgel Capsules Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Softgel Capsules Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Application
4.2.3 Analysis by Distribution Channel
5 Global Softgel Capsules Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Softgel Capsules Market Segmentation
6.1 Global Softgel Capsules Market by Type
6.1.1 Market Overview
6.1.2 Gelatin Capsules
6.1.3 Non-Gelatin Capsules
6.1.3.1 Starches
6.1.3.2 Pullulan
6.1.3.3 Others
6.2 Global Softgel Capsules Market by Application
6.2.1 Market Overview
6.2.2 Pharmaceuticals
6.2.3 Health Supplements
6.2.4 Cosmetics
6.2.5 Others
6.3 Global Softgel Capsules Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Supermarkets and Hypermarkets
6.3.3 Pharmacies and Drug Stores
6.3.4 Online Providers
6.3.5 Others
6.4 Global Softgel Capsules Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Softgel Capsules Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Softgel Capsules Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Softgel Capsules Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Softgel Capsules Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Softgel Capsules Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Sirio Pharma Co., Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Fuji Capsule Co., Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 CAPTEK® Softgel International Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Catalent, Inc
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cloverty
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Sochim International spa
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Aenova Group
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Eurocaps Limited
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Capsugel
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Procap Laboratories
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Soft gel Technologies Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Curtis Health Caps.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Softgel Capsules Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 6.1 billion in 2023, driven by advancements in pharmaceutical industry to develop capsules that have high bioavailability along with a pleasant taste, texture, and smell.
The market is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032, likely to reach a market value of USD 11.8 billion by 2032.
The ability of softgel capsules to carry liquid, semi solid, emulsions, components is a major factor for increased demand. Moreover, softgel capsules can formulate low melting point active pharmaceutical ingredients (APIs), hence, the demand will grow in the forecast period.
The rapid development in the healthcare and pharmaceutical industry with increasing investments, especially in the Asia Pacific region, is likely to aid the growth of the market.
There are both gelatine and non-gelatine softgel capsules available in the market. Non-gelatine capsules are further categorised into starches and pullulan, among others.
Softgels find wide applications in pharmaceuticals, health supplements, and cosmetics, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The distribution channels in the market are supermarkets, hypermarkets, pharmacies, drug stores, and online providers, among others.
Key players involved in the market are Sirio Pharma Co., Ltd., Fuji Capsule Co., Ltd., CAPTEK® Softgel, International Inc., Catalent, Inc, Cloverty, Sochim International spa, Aenova Group, Eurocaps Limited, Capsugel, Procap Laboratories, Soft gel Technologies Inc., and Curtis Health Caps.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.